Globus Medical Inc. Hits New 1-Year High at $24.14 (GMED)
Globus Medical (NASDAQ:GMED)’s share price hit a new 52-week high during mid-day trading on Monday , Stock Ratings Network reports. The stock traded as high as $24.14 and last traded at $23.89, with a volume of 684,083 shares traded. The stock had previously closed at $23.35.
Separately, analysts at Canaccord Genuity raised their price target on shares of Globus Medical from $26.00 to $28.00 in a research note to investors on Wednesday, January 22nd. They now have a “buy” rating on the stock. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $21.80.
The stock has a 50-day moving average of $21.55 and a 200-day moving average of $18.77. The company has a market cap of $2.237 billion and a P/E ratio of 32.03.
Globus Medical, Inc (NASDAQ:GMED) is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.